Literature DB >> 27457135

Individual differences in initial morphine sensitivity as a predictor for the development of opiate addiction in rats.

Kevin S Nishida1, Thomas Y Park1, Bong Hyo Lee2, Robert J Ursano3, Kwang H Choi4.   

Abstract

Individuals report a wide range of analgesia to similar doses of opiates, and not all opiate users become addicted. This suggests that there may be certain predispositions that influence one to develop opiate addiction. We investigated the relationship between the individual differences in initial morphine sensitivity and the subsequent development of opiate addiction-like behavior using a hot plate test and an intravenous morphine self-administration (MSA) paradigm in rats. Using a median split of initial morphine antinociception, animals were defined as low antinociception (LA) and high antinociception (HA) groups. Thus, the LA group represents the animals that were less sensitive to initial morphine antinociception as compared to those of the HA group. The animals were allowed to self-administer either saline or morphine (0.5mg/kg/infusion, 4hr/day) 5days per week for 3 weeks. Spontaneous locomotor activity was measured on self-administration days 10 and 15. Individual differences in initial morphine sensitivity were not correlated with the amount of morphine self-administered by the animals on day 1. In the second-week of MSA, the LA group exhibited increased morphine intake and locomotor hyperactivity as compared to those of the HA group. Therefore, certain animals that are less sensitive to initial morphine antinociception may be susceptible to developing opiate addiction. The current findings may have clinical implications for future research on the biological mechanisms of opiate addiction and preclinical medication development. Published by Elsevier B.V.

Entities:  

Keywords:  Drug self-administration; Locomotor activity; Morphine; Opiate addiction; Opioid analgesia; Pain

Mesh:

Substances:

Year:  2016        PMID: 27457135     DOI: 10.1016/j.bbr.2016.07.038

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Locomotor activity does not predict individual differences in morphine self-administration in rats.

Authors:  Yayi Swain; Peter Muelken; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-02-02       Impact factor: 3.533

2.  Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats.

Authors:  Yayi Swain; Peter Muelken; Annika Skansberg; Danielle Lanzdorf; Zachary Haave; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

Review 3.  Nonhuman animal models of substance use disorders: Translational value and utility to basic science.

Authors:  Mark A Smith
Journal:  Drug Alcohol Depend       Date:  2019-11-21       Impact factor: 4.492

4.  Potentiation of glutamatergic synaptic transmission onto lateral habenula neurons following early life stress and intravenous morphine self-administration in rats.

Authors:  Ludovic D Langlois; Rina Y Berman; Ryan D Shepard; Sarah C Simmons; Mumeko C Tsuda; Shawn Gouty; Kwang H Choi; Fereshteh S Nugent
Journal:  Addict Biol       Date:  2021-05-25       Impact factor: 4.280

Review 5.  Behavioral predictors of individual differences in opioid addiction vulnerability as measured using i.v. self-administration in rats.

Authors:  Yayi Swain; Jonathan C Gewirtz; Andrew C Harris
Journal:  Drug Alcohol Depend       Date:  2021-01-29       Impact factor: 4.492

6.  Concentration-related metabolic rate and behavioral thermoregulatory adaptations to serial administrations of nitrous oxide in rats.

Authors:  Karl J Kaiyala; Douglas S Ramsay
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

7.  Sex and Strain Variation in Initial Sensitivity and Rapid Tolerance to Δ9-Tetrahydrocannabinol.

Authors:  Cory Parks; Byron C Jones; Bob M Moore; Megan K Mulligan
Journal:  Cannabis Cannabinoid Res       Date:  2020-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.